Does the media refer more to STIM or MLSS?

In the previous week, Neuronetics had 6 more articles in the media than Milestone Scientific. MarketBeat recorded 7 mentions for Neuronetics and 1 mentions for Milestone Scientific. Neuronetics' average media sentiment score of 0.83 beat Milestone Scientific's score of 0.00 indicating that Neuronetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Neuronetics 2 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is MLSS or CVRX more profitable?

Milestone Scientific has a net margin of -52.01% compared to CVRx's net margin of -89.14%. Milestone Scientific's return on equity of -60.26% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets Milestone Scientific -52.01% -60.26% -40.23% CVRx -89.14% -120.76% -48.38%

Does the media prefer MLSS or CVRX?

In the previous week, CVRx had 4 more articles in the media than Milestone Scientific. MarketBeat recorded 5 mentions for CVRx and 1 mentions for Milestone Scientific. CVRx's average media sentiment score of 0.75 beat Milestone Scientific's score of 0.00 indicating that CVRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral CVRx 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer MLSS or RCEL?

In the previous week, Avita Medical had 2 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Avita Medical and 1 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.00 equaled Avita Medical'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Avita Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor MBOT or MLSS?

In the previous week, Microbot Medical and Microbot Medical both had 1 articles in the media. Microbot Medical's average media sentiment score of 0.00 equaled Milestone Scientific'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Milestone Scientific 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate KEQU or MLSS?

Milestone Scientific has a consensus price target of $1.00, indicating a potential upside of 150.63%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Kewaunee Scientific. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kewaunee Scientific 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Milestone Scientific 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Milestone Scientific (MLSS) Competitors

$0.40 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$0.40 +0.00 (+0.25%)

As of 07/31/2026 06:54 PM Eastern

Compare

MLSS vs. STIM, CVRX, RCEL, MBOT, and KEQU

Should you buy Milestone Scientific stock or one of its competitors? MarketBeat compares Milestone Scientific with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Milestone Scientific include Neuronetics (STIM), CVRx (CVRX), Avita Medical (RCEL), Microbot Medical (MBOT), and Kewaunee Scientific (KEQU). These companies are all part of the "healthcare equipment" industry.

How does Milestone Scientific compare to Neuronetics?

Neuronetics (NASDAQ:STIM) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Neuronetics has a beta of 1.06, meaning that its share price is 6% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.05, meaning that its share price is 5% more volatile than the broader market.

In the previous week, Neuronetics had 6 more articles in the media than Milestone Scientific. MarketBeat recorded 7 mentions for Neuronetics and 1 mentions for Milestone Scientific. Neuronetics' average media sentiment score of 0.83 beat Milestone Scientific's score of 0.00 indicating that Neuronetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Neuronetics	2 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

53.6% of Neuronetics shares are owned by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are owned by institutional investors. 8.4% of Neuronetics shares are owned by company insiders. Comparatively, 9.2% of Milestone Scientific shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Milestone Scientific has lower revenue, but higher earnings than Neuronetics. Milestone Scientific is trading at a lower price-to-earnings ratio than Neuronetics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Neuronetics	$151.64M	0.91	-$39M	-$0.54	N/A
Milestone Scientific	$8.90M	3.96	-$6.93M	-$0.05	N/A

Neuronetics has a net margin of -24.48% compared to Milestone Scientific's net margin of -52.01%. Milestone Scientific's return on equity of -60.26% beat Neuronetics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Neuronetics	-24.48%	-139.83%	-27.13%
Milestone Scientific	-52.01%	-60.26%	-40.23%

Neuronetics currently has a consensus price target of $4.00, indicating a potential upside of 102.02%. Milestone Scientific has a consensus price target of $1.00, indicating a potential upside of 150.63%. Given Milestone Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Milestone Scientific is more favorable than Neuronetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Neuronetics	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Neuronetics beats Milestone Scientific on 9 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to CVRx?

Milestone Scientific (NYSE:MLSS) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, dividends, earnings, valuation, profitability, risk and institutional ownership.

Milestone Scientific has a beta of 1.05, suggesting that its stock price is 5% more volatile than the broader market. Comparatively, CVRx has a beta of 0.81, suggesting that its stock price is 19% less volatile than the broader market.

Milestone Scientific presently has a consensus price target of $1.00, suggesting a potential upside of 150.63%. CVRx has a consensus price target of $11.50, suggesting a potential upside of 122.01%. Given Milestone Scientific's stronger consensus rating and higher possible upside, research analysts plainly believe Milestone Scientific is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
CVRx	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Milestone Scientific has higher earnings, but lower revenue than CVRx. Milestone Scientific is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	3.96	-$6.93M	-$0.05	N/A
CVRx	$56.65M	2.43	-$53.31M	-$2.02	N/A

In the previous week, CVRx had 4 more articles in the media than Milestone Scientific. MarketBeat recorded 5 mentions for CVRx and 1 mentions for Milestone Scientific. CVRx's average media sentiment score of 0.75 beat Milestone Scientific's score of 0.00 indicating that CVRx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
CVRx	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Milestone Scientific has a net margin of -52.01% compared to CVRx's net margin of -89.14%. Milestone Scientific's return on equity of -60.26% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
CVRx	-89.14%	-120.76%	-48.38%

5.8% of Milestone Scientific shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 9.2% of Milestone Scientific shares are owned by company insiders. Comparatively, 16.6% of CVRx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Milestone Scientific beats CVRx on 9 of the 16 factors compared between the two stocks.

How does Milestone Scientific compare to Avita Medical?

Milestone Scientific (NYSE:MLSS) and Avita Medical (NASDAQ:RCEL) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, media sentiment, earnings, risk, analyst recommendations, dividends and valuation.

5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 9.2% of Milestone Scientific shares are held by company insiders. Comparatively, 2.2% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Avita Medical had 2 more articles in the media than Milestone Scientific. MarketBeat recorded 3 mentions for Avita Medical and 1 mentions for Milestone Scientific. Milestone Scientific's average media sentiment score of 0.00 equaled Avita Medical'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Avita Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Milestone Scientific currently has a consensus target price of $1.00, indicating a potential upside of 150.63%. Avita Medical has a consensus target price of $7.25, indicating a potential upside of 64.77%. Given Milestone Scientific's stronger consensus rating and higher possible upside, analysts plainly believe Milestone Scientific is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Avita Medical	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

Milestone Scientific has a beta of 1.05, suggesting that its stock price is 5% more volatile than the broader market. Comparatively, Avita Medical has a beta of 1.86, suggesting that its stock price is 86% more volatile than the broader market.

Milestone Scientific has a net margin of -52.01% compared to Avita Medical's net margin of -62.67%. Avita Medical's return on equity of 0.00% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Milestone Scientific	-52.01%	-60.26%	-40.23%
Avita Medical	-62.67%	N/A	-78.92%

Milestone Scientific has higher earnings, but lower revenue than Avita Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Milestone Scientific	$8.90M	3.96	-$6.93M	-$0.05	N/A
Avita Medical	$72.35M	1.87	-$48.59M	-$1.57	N/A

Summary

Milestone Scientific beats Avita Medical on 8 of the 15 factors compared between the two stocks.

How does Milestone Scientific compare to Microbot Medical?

Microbot Medical (NASDAQ:MBOT) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, analyst recommendations, valuation, risk, dividends and institutional ownership.

In the previous week, Microbot Medical and Microbot Medical both had 1 articles in the media. Microbot Medical's average media sentiment score of 0.00 equaled Milestone Scientific'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Milestone Scientific	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Comparatively, 9.2% of Milestone Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Milestone Scientific has higher revenue and earnings than Microbot Medical. Milestone Scientific is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
Milestone Scientific	$8.90M	3.96	-$6.93M	-$0.05	N/A

Microbot Medical has a net margin of 0.00% compared to Milestone Scientific's net margin of -52.01%. Microbot Medical's return on equity of -21.84% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
Milestone Scientific	-52.01%	-60.26%	-40.23%

Microbot Medical has a beta of 1.06, suggesting that its share price is 6% more volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.05, suggesting that its share price is 5% more volatile than the broader market.

Microbot Medical presently has a consensus target price of $6.63, suggesting a potential upside of 285.17%. Milestone Scientific has a consensus target price of $1.00, suggesting a potential upside of 150.63%. Given Microbot Medical's higher possible upside, equities research analysts clearly believe Microbot Medical is more favorable than Milestone Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	2 Strong Buy rating(s)	3.00
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Microbot Medical beats Milestone Scientific on 8 of the 13 factors compared between the two stocks.

How does Milestone Scientific compare to Kewaunee Scientific?

Kewaunee Scientific (NASDAQ:KEQU) and Milestone Scientific (NYSE:MLSS) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, profitability, media sentiment, analyst recommendations, institutional ownership, risk, valuation and dividends.

Kewaunee Scientific has a net margin of 3.41% compared to Milestone Scientific's net margin of -52.01%. Kewaunee Scientific's return on equity of 14.10% beat Milestone Scientific's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kewaunee Scientific	3.41%	14.10%	5.55%
Milestone Scientific	-52.01%	-60.26%	-40.23%

Kewaunee Scientific has higher revenue and earnings than Milestone Scientific. Milestone Scientific is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kewaunee Scientific	$282M	0.36	$9.62M	$3.22	11.09
Milestone Scientific	$8.90M	3.96	-$6.93M	-$0.05	N/A

In the previous week, Milestone Scientific had 1 more articles in the media than Kewaunee Scientific. MarketBeat recorded 1 mentions for Milestone Scientific and 0 mentions for Kewaunee Scientific. Kewaunee Scientific's average media sentiment score of 0.00 equaled Milestone Scientific'saverage media sentiment score.

Company	Overall Sentiment
Kewaunee Scientific	Neutral
Milestone Scientific	Neutral

32.7% of Kewaunee Scientific shares are held by institutional investors. Comparatively, 5.8% of Milestone Scientific shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by insiders. Comparatively, 9.2% of Milestone Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Kewaunee Scientific has a beta of 0.72, indicating that its share price is 28% less volatile than the broader market. Comparatively, Milestone Scientific has a beta of 1.05, indicating that its share price is 5% more volatile than the broader market.

Milestone Scientific has a consensus price target of $1.00, indicating a potential upside of 150.63%. Given Milestone Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Milestone Scientific is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kewaunee Scientific	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Milestone Scientific	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Kewaunee Scientific beats Milestone Scientific on 9 of the 15 factors compared between the two stocks.

Get Milestone Scientific News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MLSS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MLSS vs. The Competition

Export

Metric	Milestone Scientific	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$35.29M	$5.58B	$6.85B	$23.65B
Dividend Yield	N/A	1.79%	2.59%	4.21%
P/E Ratio	-5.70	23.11	282.30	30.99
Price / Sales	3.96	56.82	564.25	81.82
Price / Cash	N/A	32.53	28.60	18.73
Price / Book	3.63	6.29	10.98	4.76
Net Income	-$6.93M	$151.15M	$3.49B	$1.07B
7 Day Performance	-0.84%	1.02%	-0.60%	-0.34%
1 Month Performance	16.56%	-3.44%	-5.19%	-0.53%
1 Year Performance	-7.36%	2.34%	62.02%	19.19%

Milestone Scientific Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MLSS Milestone Scientific	1.2004 of 5 stars	$0.40 flat	$1.00 +150.6%	-7.4%	$35.29M	$8.90M	N/A	30
STIM Neuronetics	3.7004 of 5 stars	$1.98 +0.5%	$4.00 +102.0%	-55.2%	$137.78M	$149.16M	N/A	180
CVRX CVRx	2.1003 of 5 stars	$5.18 -3.7%	$11.50 +122.0%	-31.5%	$137.32M	$56.65M	N/A	160	Positive News Upcoming Earnings
RCEL Avita Medical	2.6165 of 5 stars	$4.40 -2.0%	$7.25 +64.8%	-14.7%	$135.42M	$71.61M	N/A	130	News Coverage Upcoming Earnings Analyst Upgrade
MBOT Microbot Medical	1.7641 of 5 stars	$1.72 -1.1%	$6.63 +285.2%	-32.5%	$115.52M	N/A	N/A	20

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:MLSS) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Milestone Scientific (MLSS) Competitors

MLSS vs. STIM, CVRX, RCEL, MBOT, and KEQU

How does Milestone Scientific compare to Neuronetics?

Summary

How does Milestone Scientific compare to CVRx?

Summary

How does Milestone Scientific compare to Avita Medical?

Summary

How does Milestone Scientific compare to Microbot Medical?

Summary

How does Milestone Scientific compare to Kewaunee Scientific?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Milestone Scientific (MLSS) Competitors

MLSS vs. STIM, CVRX, RCEL, MBOT, and KEQU

How does Milestone Scientific compare to Neuronetics?

Which has more risk and volatility, STIM or MLSS?

Does the media refer more to STIM or MLSS?

Do institutionals & insiders believe in STIM or MLSS?

Which has higher earnings and valuation, STIM or MLSS?

Is STIM or MLSS more profitable?

Do analysts prefer STIM or MLSS?

Summary

How does Milestone Scientific compare to CVRx?

Which has more risk and volatility, MLSS or CVRX?

Do analysts rate MLSS or CVRX?

Which has better earnings & valuation, MLSS or CVRX?

Does the media prefer MLSS or CVRX?

Is MLSS or CVRX more profitable?

Do institutionals and insiders hold more shares of MLSS or CVRX?

Summary

How does Milestone Scientific compare to Avita Medical?

Do insiders & institutionals believe in MLSS or RCEL?

Does the media prefer MLSS or RCEL?

Do analysts rate MLSS or RCEL?

Which has more risk & volatility, MLSS or RCEL?

Is MLSS or RCEL more profitable?

Which has higher earnings & valuation, MLSS or RCEL?

Summary

How does Milestone Scientific compare to Microbot Medical?

Does the media favor MBOT or MLSS?

Do insiders and institutionals hold more shares of MBOT or MLSS?

Which has better earnings and valuation, MBOT or MLSS?

Is MBOT or MLSS more profitable?

Which has more risk & volatility, MBOT or MLSS?

Do analysts prefer MBOT or MLSS?

Summary

How does Milestone Scientific compare to Kewaunee Scientific?

Is KEQU or MLSS more profitable?

Which has higher earnings and valuation, KEQU or MLSS?

Does the media favor KEQU or MLSS?

Do insiders & institutionals believe in KEQU or MLSS?

Which has more volatility & risk, KEQU or MLSS?

Do analysts rate KEQU or MLSS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MLSS vs. The Competition

Milestone Scientific Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools